Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials
Polycystic ovary syndrome (PCOS) is a common endocrine disorder, with complex etiology and pathophysiology, which remains poorly understood. It affects about 5–10% of women of reproductive age who typically suffer from obesity, hyperandrogenism, ovarian dysfunction, and menstrual irregularity. Indee...
Saved in:
Main Authors: | Vittorio Unfer, John E. Nestler, Zdravko A. Kamenov, Nikos Prapas, Fabio Facchinetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2016/1849162 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inositol(s) from Bench to Bedside in Endocrinology and Gynecology
by: Vittorio Unfer, et al.
Published: (2017-01-01) -
A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women
by: Elena Benelli, et al.
Published: (2016-01-01) -
Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
by: Paola Quaresima, et al.
Published: (2025-01-01) -
Corrigendum to “The Efficacy of Inositol and N-Acetyl Cysteine Administration (Ovaric HP) in Improving the Ovarian Function in Infertile Women with PCOS with or without Insulin Resistance”
by: Angela Sacchinelli, et al.
Published: (2016-01-01) -
Improved insulin sensitivity and reproductive profile in overweight/obese PCOS patients undergoing integrative treatment with carnitines, L-arginine, L-cysteine and myo-inositol
by: Alessandro D. Genazzani, et al.
Published: (2025-12-01)